Credit Suisse’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-10,210
| Closed | -$23K | – | 3452 |
|
|
2020
Q4 | $23K | Buy |
+10,210
| New | +$23K | ﹤0.01% | 3440 |
|
|
2019
Q3 | – | Sell |
-17,384
| Closed | -$72K | – | 3447 |
|
|
2019
Q2 | $72K | Sell |
17,384
-183,340
| -91% | -$759K | ﹤0.01% | 3328 |
|
|
2019
Q1 | $1.03M | Buy |
+200,724
| New | +$1.03M | ﹤0.01% | 2350 |
|
|
2016
Q3 | – | Sell |
-60,617
| Closed | -$89K | – | 3768 |
|
|
2016
Q2 | $89K | Sell |
60,617
-979
| -2% | -$1.44K | ﹤0.01% | 3768 |
|
|
2016
Q1 | $88K | Sell |
61,596
-1,389
| -2% | -$1.98K | ﹤0.01% | 3538 |
|
|
2015
Q4 | $103K | Buy |
62,985
+2,373
| +4% | +$3.88K | ﹤0.01% | 3840 |
|
|
2015
Q3 | $141K | Sell |
60,612
-24,994
| -29% | -$58.1K | ﹤0.01% | 3823 |
|
|
2015
Q2 | $234K | Buy |
85,606
+18,569
| +28% | +$50.8K | ﹤0.01% | 3855 |
|
|
2015
Q1 | $226K | Sell |
67,037
-24,178
| -27% | -$81.5K | ﹤0.01% | 3737 |
|
|
2014
Q4 | $316K | Buy |
91,215
+18,019
| +25% | +$62.4K | ﹤0.01% | 3657 |
|
|
2014
Q3 | $368K | Buy |
73,196
+27,114
| +59% | +$136K | ﹤0.01% | 3444 |
|
|
2014
Q2 | $636K | Sell |
46,082
-18,549
| -29% | -$256K | ﹤0.01% | 3251 |
|
|
2014
Q1 | $989K | Buy |
64,631
+51,777
| +403% | +$792K | ﹤0.01% | 2796 |
|
|
2013
Q4 | $104K | Buy |
+12,854
| New | +$104K | ﹤0.01% | 4007 |
|